(Q72760496)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

G M Kochak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

R L Choi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

E A Entwistle

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

1760-1764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

The effect of food on the relative bioavailability of fadrozole hydrochloride.

29 October 2019

cites work

1 reference

12 December 2020

Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol

1 reference

12 December 2020

A phase I trial of CGS 16949A. A new aromatase inhibitor

1 reference

12 December 2020

Effects of low-density lipoprotein and ethinyl estradiol on cyclosporine metabolism in isolated rat liver perfusions

1 reference

12 December 2020

Androgen and estrogen metabolism: relationship to obesity

1 reference

12 December 2020

Effects of ethinyl estradiol on hepatic microsomal proteins and the turnover of cytochrome P-450

1 reference

12 December 2020

Inhibition of aromatase with CGS 16949A in postmenopausal women

1 reference

12 December 2020

Intra- and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617.

1 reference

12 December 2020

Production of Estrone and Fractional Conversion of Circulating Androstenedione to Estrone in Women with Endometrial Carcinoma

1 reference

12 December 2020

Population characteristics of biological systems influenced by multicomponent random and uniform variation

1 reference

12 December 2020

CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer--a phase I study

1 reference

12 December 2020

Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450

1 reference

12 December 2020

Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer

1 reference

12 December 2020

The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018930316215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8302763%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference